Choate Investment Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Buy
1,272
+3
+0.2% +$789 0.01% 374
2026
Q1
$339K Sell
1,269
-4
-0.3% -$1.08K 0.01% 363
2025
Q4
$319K Hold
1,273
0.01% 367
2025
Q3
$365K Hold
1,273
0.01% 331
2025
Q2
$334K Sell
1,273
-42
-3% -$10.2K 0.01% 325
2025
Q1
$306K Sell
1,315
-26
-2% -$6.31K 0.01% 322
2024
Q4
$308K Buy
1,341
+98
+8% +$22.5K 0.01% 321
2024
Q3
$278K Sell
1,243
-242
-16% -$53.2K 0.01% 329
2024
Q2
$302K Buy
1,485
+235
+19% +$47.8K 0.01% 301
2024
Q1
$273K Sell
1,250
-2
-0.2% -$441 0.01% 343
2023
Q4
$285K Buy
1,252
+104
+9% +$21.8K 0.01% 313
2023
Q3
$231K Buy
+1,148
New +$242K 0.01% 328
2014
Q3
Sell
-2,448
Closed -$215K 286
2014
Q2
$215K Sell
2,448
-1,525
-38% -$132K 0.01% 253
2014
Q1
$335K Buy
3,973
+134
+3% +$10.7K 0.02% 217
2013
Q4
$301K Buy
3,839
+1,304
+51% +$111K 0.02% 225
2013
Q3
$216K Buy
2,535
+93
+4% +$7.83K 0.02% 244
2013
Q2
$210K Buy
+2,442
New +$203K 0.02% 247

Other funds holding LH

Choate Investment Advisors's LH Position: Q2 2026 in Review

Choate Investment Advisors increased its Labcorp (LH) stake by 0.24% in Q2 2026, buying an estimated $789 and bringing the position to 1,272 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #374.

Choate Investment Advisors first reported a position in LH in Q2 2013 and has held it in 17 quarters since. The position peaked at $365K in Q3 2025. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Choate Investment Advisors held 1,272 shares of Labcorp worth $356K as of Q2 2026.
  • Choate Investment Advisors bought 3 Labcorp shares in Q2 2026, an estimated $789.
  • Labcorp made up 0.01% of Choate Investment Advisors's portfolio in Q2 2026, its #374 holding.
  • Choate Investment Advisors first reported a position in Labcorp in Q2 2013 and has held it in 17 quarters since.
  • Choate Investment Advisors's Labcorp position peaked at $365K in Q3 2025.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Choate Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.